CEO Dr Satu Vainikka discusses ValiRx, the life sciences company focusing on clinical stage cancer therapeutics.

Download and read the presentation here

Previous articleCranswick shares jump on ‘encouraging’ quarter
Next articleKodal Minerals presents at the UK Investor Magazine Summer Investor Evening July 18th 2019
Avatar photo
This is the profile of the UK Investor Magazine team who, in collaboration with each other and our partners, produce a number of in-depth analytical articles, reviews of investment services and publish sponsored articles from carefully selected partners.